子痫前期中的合体滋养细胞应激:多种通路的汇聚点
子痫前期分两阶段:胎盘问题产生信号引发母体综合征。早发型第一阶段为胎盘形成不良,晚发型(约80%)为胎盘功能随妊娠进展下降。两型第二阶段均以合体滋养细胞应激为关键特征,是母体综合征的原因,也是最具特异性的生物标志物来源。
要点
- 早发型子痫前期第一阶段为螺旋动脉重塑不全,持续时间长,常伴胎儿生长受限。
- 晚发型约占80%,第一阶段短,因胎盘超出子宫容量致合体滋养细胞应激。
- 合体滋养细胞应激信号是最特异生物标志物,sFlt-1已常规用于临床。
核心结论
- 早发型与晚发型子痫前期通过不同通路汇聚于合体滋养细胞应激这一共同病理终点,导致母体综合征。
研究设计与样本
- 本文为综述,未报告系统检索范围与样本量。
主要发现
- 早发型第一阶段为胎盘形成不良,螺旋动脉重塑不全,持续时间数月,与胎儿生长受限相关。
- 晚发型约占全部病例80%,第一阶段仅数周,胎盘功能因绒毛膜绒毛密集、绒毛间隙受压及胎儿缺氧而下降。
- 正常妊娠中合体滋养细胞应激信号平均于30至32周开始并进展至足月。
- 足月时合体滋养细胞显示凋亡、焦亡、自噬、合体结节和坏死等应激标志增加,称为「暮光胎盘」。
- 子痫前期的异质性源于不同通路到达同一终点,受母体遗传、表观遗传、生活方式和环境因素影响。
临床怎么用
- 合体滋养细胞应激信号可作为子痫前期最特异的生物标志物。
- sFlt-1由合体滋养细胞主要产生,已在许多地区常规用于临床。
- 需重新评估子痫前期的预测和预防策略。
局限性
- 本文为综述,未报告系统检索策略及纳入研究的具体样本量与统计值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Preeclampsia evolves in 2 stages: a placental problem that generates signals to the mother to cause a range of responses that comprise the second stage (preeclampsia syndrome). The first stage of early-onset preeclampsia is poor placentation, which we here call malplacentation. The spiral arteries are incompletely remodeled, leading to later placental malperfusion, relatively early in the second half of pregnancy. The long duration of the first stage (several months) is unsurprisingly associated with fetal growth restriction. The first stage of late-onset preeclampsia, approximately 80% of total cases, is shorter (several weeks) and part of a process that is common to all pregnancies. Placental function declines as it outgrows uterine capacity, with increasing chorionic villous packing, compression of the intervillous space, and fetal hypoxia, and causes late-onset clinical presentations such as "unexplained" stillbirths, late-onset fetal growth restriction, or preeclampsia. The second stages of early- and late-onset preeclampsia share syncytiotrophoblast stress as the most relevant feature that causes the maternal syndrome. Syncytiotrophoblast stress signals in the maternal circulation are probably the most specific biomarkers for preeclampsia. In addition, soluble fms-like tyrosine kinase-1 (mainly produced by syncytiotrophoblast) is the best-known biomarker and is routinely used in clinical practice in many locations. How the stress signals change over time in normal pregnancies indicates that syncytiotrophoblast stress begins on average at 30 to 32 weeks' gestation and progresses to term. At term, syncytiotrophoblast shows increasing markers of stress, including apoptosis, pyroptosis, autophagy, syncytial knots, and necrosis. We label this phenotype the "twilight placenta" and argue that it accounts for the clinical problems of postmature pregnancies. Senescence as a stress response differs in multinuclear syncytiotrophoblast from that of mononuclear cells. Syncytiotrophoblast irreversibly acquires part of the senescence phenotype (cell cycle arrest) when it is formed by cell fusion. The 2 pathways converge on the common pathologic endpoint, syncytiotrophoblast stress, and contribute to preeclampsia subtypes. We highlight that the well-known heterogeneity of the preeclampsia syndrome arises from different pathways to this common endpoint, influenced by maternal genetics, epigenetics, lifestyle, and environmental factors with different fetal and maternal responses to the ensuing insults. This complexity mandates a reassessment of our approach to predicting and preventing preeclampsia, and we summarize research priorities to maximize what we can learn about these important issues.
引用
- Redman CWG, Staff AC, Roberts JM, et al. Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways. Am J Obstet Gynecol. 2021. PMID: 33546842. doi:10.1016/j.ajog.2020.09.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。